- Report
- January 2022
- 60 Pages
Global
From €3750EUR$3,950USD£3,163GBP
- Report
- January 2022
- 60 Pages
Global
From €3750EUR$3,950USD£3,163GBP
- Report
- January 2022
- 60 Pages
Global
From €3750EUR$3,950USD£3,163GBP
- Report
- January 2022
- 60 Pages
Global
From €3750EUR$3,950USD£3,163GBP
- Report
- January 2021
- 38 Pages
Global
€1251EUR$1,318USD£1,055GBP
- Report
- August 2020
- 112 Pages
Global
From €4035EUR$4,250USD£3,403GBP
- Report
- December 2023
- 62 Pages
Global
From €9489EUR$9,995USD£8,004GBP
- Clinical Trials
- November 2021
- 425 Pages
Global
From €2373EUR$2,500USD£2,002GBP
- Report
- August 2022
United States
From €1842EUR$1,940USD£1,554GBP
- Report
- August 2022
Global
From €750EUR$790USD£633GBP
- Report
- February 2024
- 25 Pages
Global
€16281EUR$17,150USD£13,733GBP
- Report
- October 2024
- 103 Pages
Global
From €3500EUR$3,949USD£3,056GBP
- Report
- May 2023
- 112 Pages
Global
From €3500EUR$3,949USD£3,056GBP
- Report
- October 2022
- 133 Pages
Global
From €1899EUR$2,000USD£1,602GBP
The Gout Drug market is a subset of the Immune Disorders Drugs market, which includes treatments for a variety of conditions related to the immune system. Gout drugs are used to reduce the inflammation and pain associated with gout, a type of arthritis caused by the buildup of uric acid in the joints. These drugs can be taken orally or injected directly into the affected joint. Commonly prescribed gout drugs include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and colchicine.
Gout drugs are typically prescribed by a doctor and are available in both generic and brand-name forms. The cost of these drugs can vary depending on the type of drug, the dosage, and the form in which it is taken.
Some companies in the Gout Drug market include Pfizer, Merck, Novartis, and Sanofi. Show Less Read more
